发明公开
EP1539806A2 THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THE SAME, AND METHODS OF USE
审中-公开
治疗性多肽，编码该核酸的核酸及使用方法
- 专利标题： THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THE SAME, AND METHODS OF USE
- 专利标题（中）： 治疗性多肽，编码该核酸的核酸及使用方法
-
申请号： EP02741692.4申请日： 2002-05-02
-
公开(公告)号： EP1539806A2公开(公告)日： 2005-06-15
- 发明人: ALSOBROOK, John P. II , ANDERSON, David W. , BOLDOG, Ferenc L. , BURGESS, Catherine E. , CASMAN, Stacie J. , EDINGER, Schlomit R. , ELLERMAN, Karen , GANGOLLI, Esha A. , GERLACH, Valerie L. , GORMAN, Linda , GUNTHER, Erik , HERRMANN, John L. , JI, Weizhen , LEPLEY, Denise M. , LEWIN, David A. , LI, Li , MACDOUGALL, John R. , MALYANKAR, Uriel M. , MEZES, Peter D. , PADIGARU, Muralidhara , PATTURAJAN, Meera , PEYMAN, John A. , RASTELLI, Luca , RIEGER, Daniel K. , ROTHENBERG, Mark E. , SHENOY, Suresh G. , SMITHSON, Glennda , SPYTEK, Kimberly A. , STONE, David J. , TAUPIER, Raymond J., Jr. , TCHERNEV, Velizar T. , VERNET, Corine A. M. , VOSS, Edward Z. , ZERHUSEN, Bryan D. , ZHONG, Haihong , MILLER, Charles E.
- 申请人： Curagen Corporation
- 申请人地址： 11th floor, 555 Long Wharf Drive New Haven, CT 06511 US
- 专利权人： Curagen Corporation
- 当前专利权人： Curagen Corporation
- 当前专利权人地址： 11th floor, 555 Long Wharf Drive New Haven, CT 06511 US
- 代理机构： Naylor, Kathryn May
- 优先权： US288395P 20010503; US289087P 20010507; US289620P 20010508; US289621P 20010508; US289817P 20010509; US289818P 20010509; US290194P 20010511; US290753P 20010514; US291189P 20010515; US291243P 20010516; US292001P 20010518; US292374P 20010521; US292587P 20010522; US293107P 20010523; US293589P 20010524; US293747P 20010525; US294110P 20010529; US294434P 20010530; US312192P 20010814; US313173P 20010817; US313187P 20010817; US318728P 20010912; US318744P 20010912; US335910P 20011115; US333942P 20011128; US345776P 20020103; US345220P 20020104; US136071 20020501; US333891 20011128
- 国际公布： WO2002090568 20021114
- 主分类号： C07K14/00
- IPC分类号： C07K14/00 ; A61K38/17 ; G01N33/53
摘要：
Disclosed herein are nucleic acid sequences that encode G-coupled protein-receptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the-polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
信息查询
